Key result
Metabolic syndrome significantly altered the cardiac gene expression profile in male ZDF rats, resulting in 36 up-regulated and 49 down-regulated genes compared to lean controls.
Why the study?
Does metabolic syndrome alter cardiac gene expression patterns in male ZDF rats?
Does metabolic syndrome alter cardiac gene expression patterns in male ZDF rats?
p-value: p=<0.05
Metabolic syndrome significantly alters the cardiac gene expression profile in ZDF rats, affecting genes related to metabolism, structural proteins, signal transduction, and stress response.
Does not inform clinical care; leaves open mechanistic contributions of these genes to human diabetic cardiomyopathy.
BACKGROUND: Metabolic syndrome (coexisting visceral obesity, dyslipidemia, hyperglycemia, and hypertension) is a prominent risk factor for cardiovascular morbidity and mortality, however, its effect on cardiac gene expression pattern is unclear. Therefore, we examined the possible alterations in cardiac gene expression pattern in male Zucker Diabetic Fatty (ZDF) rats, a model of metabolic syndrome. METHODS: Fasting blood glucose, serum insulin, cholesterol and triglyceride levels were measured at 6, 16, and 25 wk of age in male ZDF and lean control rats. Oral glucose tolerance test was performed at 16 and 25 wk of age. At week 25, total RNA was isolated from the myocardium and assayed by rat oligonucleotide microarray for 14921 genes. Expression of selected genes was confirmed by qRT-PCR. RESULTS: Fasting blood glucose, serum insulin, cholesterol and triglyceride levels were significantly increased, glucose tolerance and insulin sensitivity were impaired in ZDF rats compared to leans. In hearts of ZDF rats, 36 genes showed significant up-regulation and 49 genes showed down-regulation as compared to lean controls. Genes with significantly altered expression in the heart due to metabolic syndrome includes functional clusters of metabolism (e.g. 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2; argininosuccinate synthetase; 2-amino-3-ketobutyrate-coenzyme A ligase), structural proteins (e.g. myosin IXA; aggrecan1), signal transduction (e.g. activating transcription factor 3; phospholipase A2; insulin responsive sequence DNA binding protein-1) stress response (e.g. heat shock 70kD protein 1A; heat shock protein 60; glutathione S-transferase Yc2 subunit), ion channels and receptors (e.g. ATPase, (Na+)/K+ transporting, beta 4 polypeptide; ATPase, H+/K+ transporting, nongastric, alpha polypeptide). Moreover some other genes with no definite functional clusters were also changed such as e.g. S100 calcium binding protein A3; ubiquitin carboxy-terminal hydrolase L1; interleukin 18. Gene ontology analysis revealed several significantly enriched functional inter-relationships between genes influenced by metabolic syndrome. CONCLUSIONS: Metabolic syndrome significantly alters cardiac gene expression profile which may be involved in development of cardiac pathologies in the presence of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Sárközy et al. (2013) studied Metabolic syndrome (n=16). Metabolic syndrome (ZDF rat model) vs. Lean control rats was evaluated on Differentially expressed cardiac genes (p=<0.05). Metabolic syndrome significantly altered the cardiac gene expression profile in male ZDF rats, resulting in 36 up-regulated and 49 down-regulated genes compared to lean controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: